194 related articles for article (PubMed ID: 17264824)
1. Dried blood spot measurement of tacrolimus is promising for patient monitoring.
Hoogtanders K; van der Heijden J; Christiaans M; van de Plas A; van Hooff J; Stolk L
Transplantation; 2007 Jan; 83(2):237-8. PubMed ID: 17264824
[TBL] [Abstract][Full Text] [Related]
2. Dried blood spot measurement: application in tacrolimus monitoring using limited sampling strategy and abbreviated AUC estimation.
Cheung CY; van der Heijden J; Hoogtanders K; Christiaans M; Liu YL; Chan YH; Choi KS; van de Plas A; Shek CC; Chau KF; Li CS; van Hooff J; Stolk L
Transpl Int; 2008 Feb; 21(2):140-5. PubMed ID: 17944802
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
Bartlomiejczyk I; Zochowska D; Sanko-Resmer J; Matuszewicz D; Paczek L
Transplant Proc; 2006; 38(1):94-6. PubMed ID: 16504673
[TBL] [Abstract][Full Text] [Related]
4. Clinical Validation of Simultaneous Analysis of Tacrolimus, Cyclosporine A, and Creatinine in Dried Blood Spots in Kidney Transplant Patients.
Veenhof H; Koster RA; Alffenaar JC; Berger SP; Bakker SJL; Touw DJ
Transplantation; 2017 Jul; 101(7):1727-1733. PubMed ID: 27906832
[TBL] [Abstract][Full Text] [Related]
5. Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery.
Koster RA; Alffenaar JW; Greijdanus B; Uges DR
Talanta; 2013 Oct; 115():47-54. PubMed ID: 24054560
[TBL] [Abstract][Full Text] [Related]
6. Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls.
Edelbroek PM; van der Heijden J; Stolk LM
Ther Drug Monit; 2009 Jun; 31(3):327-36. PubMed ID: 19349929
[TBL] [Abstract][Full Text] [Related]
7. Falsely abnormally elevated blood trough concentration of tacrolimus measured by antibody-conjugated magnetic immunoassay in a renal transplant recipient: a case report.
Toraishi T; Takeuchi H; Nakamura Y; Konno O; Yokoyama T; Iwamoto H; Hama K; Hirano T; Unezaki S; Okuyama K; Shimazu M
Transplant Proc; 2012 Jan; 44(1):134-6. PubMed ID: 22310597
[TBL] [Abstract][Full Text] [Related]
8. Volumetric absorptive microsampling and dried blood spot microsampling vs. conventional venous sampling for tacrolimus trough concentration monitoring.
Veenhof H; Koster RA; Junier LAT; Berger SP; Bakker SJL; Touw DJ
Clin Chem Lab Med; 2020 Sep; 58(10):1687-1695. PubMed ID: 32412437
[TBL] [Abstract][Full Text] [Related]
9. Dried Blood Spot Sampling for Tacrolimus and Mycophenolic Acid in Children: Analytical and Clinical Validation.
Martial LC; Hoogtanders KEJ; Schreuder MF; Cornelissen EA; van der Heijden J; Joore MA; Van Maarseveen EM; Burger DM; Croes S; Brüggemann RJM; Aarnoutse RE
Ther Drug Monit; 2017 Aug; 39(4):412-421. PubMed ID: 28700522
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometry.
van der Heijden J; de Beer Y; Hoogtanders K; Christiaans M; de Jong GJ; Neef C; Stolk L
J Pharm Biomed Anal; 2009 Nov; 50(4):664-70. PubMed ID: 19155152
[TBL] [Abstract][Full Text] [Related]
11. Clinical validation of dried blood spot sampling in therapeutic drug monitoring of ciclosporin A in allogeneic stem cell transplant recipients: direct comparison between capillary and venous sampling.
Wilhelm AJ; Klijn A; den Burger JC; Visser OJ; Veldkamp AI; Janssen JJ; Swart EL
Ther Drug Monit; 2013 Feb; 35(1):92-5. PubMed ID: 23296096
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring of ciclosporin A and tacrolimus in heart lung transplant patients using dried blood spots.
Hinchliffe E; Adaway J; Fildes J; Rowan A; Keevil BG
Ann Clin Biochem; 2014 Jan; 51(Pt 1):106-9. PubMed ID: 23939194
[TBL] [Abstract][Full Text] [Related]
13. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
Akbas SH; Ozdem S; Caglar S; Tuncer M; Gurkan A; Yucetin L; Senol Y; Demirbas A; Gultekin M; Ersoy FF; Akaydin M
Clin Biochem; 2005 Jun; 38(6):552-7. PubMed ID: 15885236
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic drug monitoring of tacrolimus with the dried blood spot method.
Hoogtanders K; van der Heijden J; Christiaans M; Edelbroek P; van Hooff JP; Stolk LM
J Pharm Biomed Anal; 2007 Jul; 44(3):658-64. PubMed ID: 17184953
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device.
Zwart TC; Gokoel SRM; van der Boog PJM; de Fijter JW; Kweekel DM; Swen JJ; Guchelaar HJ; Moes DJAR
Br J Clin Pharmacol; 2018 Dec; 84(12):2889-2902. PubMed ID: 30176064
[TBL] [Abstract][Full Text] [Related]
16. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
Westley IS; Taylor PJ; Salm P; Morris RG
Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients.
Akbas SH; Yavuz A; Tuncer M; Yurdakonar E; Akcit F; Gurkan A; Demirbas A; Gultekin M; Ersoy F; Akaydin M
Transplant Proc; 2004; 36(1):86-8. PubMed ID: 15013308
[TBL] [Abstract][Full Text] [Related]
18. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
[TBL] [Abstract][Full Text] [Related]
19. Limited sampling strategy for prolonged-release tacrolimus in renal transplant patients by use of the dried blood spot technique.
van Boekel GA; Donders AR; Hoogtanders KE; Havenith TR; Hilbrands LB; Aarnoutse RE
Eur J Clin Pharmacol; 2015 Jul; 71(7):811-6. PubMed ID: 25980838
[TBL] [Abstract][Full Text] [Related]
20. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
Ventura E; Bonardet A; Pageaux GP; Mourad G; Cristol JP
Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
